Top News SNP 1 March 2024 The ANR project “CadoRNA” started in march 2024 The “CadoRNA” ANR project funded in 2023 (project ANR-23-CE18-0014) started start in March 2024. This research project coordinated by Alexandre Specht will be carried out in collaboration with the groups of Françoise Pons, Pascal Didier (LBP, UMR 7021) and Mei Li (IGBMC, UMR 7104 – UMR-S 1258).… SNP 1 March 2024 The SATT Conectus Alsace Maturation project “MucoLip” started in march 2024 Following a pre-maturation phase, the “MucoLip” project (Project leaders: Françoise Pons & Luc Lebeau) entered in a maturation phase (funding from SATT Conectus Alsace). This project aims to develop auxiliary lipids to confer intrinsic mucolytic activity to lipidic nanoparticles for the release of… Top News SNP 22 December 2023 Light Targeted transgene expression in the eye validated in a mouse model In this work carried out in collaboration with the team of Dr. Sidney Cambridge at the University of Frankfurt, we demonstrate a first step towards the development of targeted light-mediated gene therapy in the eye.
Top News SNP 1 March 2024 The ANR project “CadoRNA” started in march 2024 The “CadoRNA” ANR project funded in 2023 (project ANR-23-CE18-0014) started start in March 2024. This research project coordinated by Alexandre Specht will be carried out in collaboration with the groups of Françoise Pons, Pascal Didier (LBP, UMR 7021) and Mei Li (IGBMC, UMR 7104 – UMR-S 1258).…
SNP 1 March 2024 The SATT Conectus Alsace Maturation project “MucoLip” started in march 2024 Following a pre-maturation phase, the “MucoLip” project (Project leaders: Françoise Pons & Luc Lebeau) entered in a maturation phase (funding from SATT Conectus Alsace). This project aims to develop auxiliary lipids to confer intrinsic mucolytic activity to lipidic nanoparticles for the release of…
Top News SNP 22 December 2023 Light Targeted transgene expression in the eye validated in a mouse model In this work carried out in collaboration with the team of Dr. Sidney Cambridge at the University of Frankfurt, we demonstrate a first step towards the development of targeted light-mediated gene therapy in the eye.